Cargando…
Ultrapotent miniproteins targeting the SARS-CoV-2 receptor-binding domain protect against infection and disease
Despite the introduction of public health measures and spike protein-based vaccines to mitigate the COVID-19 pandemic, SARS-CoV-2 infections and deaths continue to have a global impact. Previously, we used a structural design approach to develop picomolar range miniproteins targeting the SARS-CoV-2...
Autores principales: | Case, James Brett, Chen, Rita E., Cao, Longxing, Ying, Baoling, Winkler, Emma S., Johnson, Max, Goreshnik, Inna, Pham, Minh N., Shrihari, Swathi, Kafai, Natasha M., Bailey, Adam L., Xie, Xuping, Shi, Pei-Yong, Ravichandran, Rashmi, Carter, Lauren, Stewart, Lance, Baker, David, Diamond, Michael S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8221914/ https://www.ncbi.nlm.nih.gov/pubmed/34192518 http://dx.doi.org/10.1016/j.chom.2021.06.008 |
Ejemplares similares
-
Ultrapotent miniproteins targeting the receptor-binding domain protect against SARS-CoV-2 infection and disease in mice
por: Case, James Brett, et al.
Publicado: (2021) -
De novo design of picomolar SARS-CoV-2 miniprotein inhibitors
por: Cao, Longxing, et al.
Publicado: (2020) -
Ultrapotent and broad neutralization of SARS-CoV-2 variants by modular, tetravalent, bi-paratopic antibodies
por: Miersch, Shane, et al.
Publicado: (2022) -
Design and Engineering of Miniproteins
por: Ożga, Katarzyna, et al.
Publicado: (2022) -
Multivalency transforms SARS-CoV-2 antibodies into ultrapotent neutralizers
por: Rujas, Edurne, et al.
Publicado: (2021)